Let-7f-5p suppresses Th17 differentiation via targeting STAT3 in multiple sclerosis

Area of Science:

• Immunology
• Neuroscience
• Molecular Biology

Background:

• T helper 17 (Th17) cells play a crucial role in the pathogenesis of multiple sclerosis (MS).
• The specific roles of microRNAs (miRNAs) in Th17 cell differentiation and MS development are not fully understood.
• Identifying regulatory mechanisms of Th17 cells is vital for understanding MS pathogenesis.

Purpose of the Study:

• To investigate the role of let-7f-5p in Th17 cell differentiation.
• To elucidate the molecular mechanism by which let-7f-5p regulates Th17 differentiation in the context of MS.
• To identify let-7f-5p as a potential therapeutic target for MS.

Main Methods:

• Quantification of let-7f-5p expression in CD4+ T cells from MS patients and during Th17 differentiation.
• Manipulation of let-7f-5p levels (overexpression and knockdown) to assess its effect on Th17 differentiation.
• Identification of let-7f-5p targets using molecular biology techniques.
• Analysis of STAT3 and p-STAT3 protein levels in relation to let-7f-5p expression.

Main Results:

• let-7f-5p expression was significantly downregulated in CD4+ T cells from MS patients and during Th17 differentiation.
• Overexpression of let-7f-5p suppressed Th17 differentiation, while its knockdown enhanced it.
• Signal transducer and activator of transcription 3 (STAT3) was identified as a direct target of let-7f-5p.
• STAT3 and p-STAT3 protein levels were inversely correlated with let-7f-5p expression in MS patients' T cells.

Conclusions:

• let-7f-5p acts as an inhibitor of Th17 cell differentiation.
• let-7f-5p targets STAT3, a key transcription factor in Th17 cells.
• let-7f-5p represents a potential therapeutic target for multiple sclerosis by modulating Th17 cell differentiation.